Silo Pharma, Inc. (SILO) Financials

$1.06

north_east
$0.02 (1.92%)
Day's range
$1
Day's range
$1.07
$4M$4M$2M$2M$0$0-$2M-$2M-$4M-$4M-$6M-$6MEarning2018201820192019202020202021202120222022202320232024202415000%15000%10000%10000%5000%5000%0%0%-5000%-5000%-10000%-10000%Profit Margin
Profit Margin
Revenue
Earnings

SILO Income statement / Annual

Last year (2024), Silo Pharma, Inc.'s total revenue was $72,102.00, a decrease of 0.00% from the previous year. In 2024, Silo Pharma, Inc.'s net income was -$4.39 M. See Silo Pharma, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $72,102.00 $72,102.00 $72,102.00 $71,264.00 $40,923.00 $40,569.00 $0.00 $847,407.00 -$669,480.00 -$145,185.00
Cost of Revenue $5,838.00 $5,838.00 $5,838.00 $5,004.00 $176,126.00 $27,387.00 $17,550.00 $0.00 $0.00 $0.00
Gross Profit $66,264.00 $66,264.00 $66,264.00 $66,260.00 -$135,203.00 $13,182.00 -$17,550.00 $847,407.00 -$669,480.00 -$145,185.00
Gross Profit Ratio 0.92 0.92 0.92 0.93 -3.3 0.32 0 1 1 1
Research and Development Expenses $2.37 M $845,092.00 $1.29 M $693,910.00 $88,800.00 $63,465.00 $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $1.20 M $3.08 M $2.43 M $2.27 M $2.18 M $864,180.00 $459,830.00 $313,371.00 $300,994.00 $167,700.00
Selling & Marketing Expenses -$900,461.00 $0.00 -$1.27 M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $298,284.00 $3.08 M $2.43 M $2.27 M $2.18 M $864,180.00 $459,830.00 $313,371.00 $300,994.00 $167,700.00
Other Expenses $2.11 M $0.00 $2.17 M $1.95 M $3,000.00 $765,720.00 $314,607.00 $177,500.00 $142,500.00 $96,613.00
Operating Expenses $4.77 M $3.92 M $3.71 M $2.96 M $2.27 M $927,645.00 $459,830.00 $490,871.00 $443,494.00 $264,313.00
Cost And Expenses $4.78 M $3.93 M $3.72 M $2.96 M $2.45 M $955,032.00 $459,830.00 $427,961.00 $443,494.00 $264,313.00
Interest Income $333,165.00 $398,530.00 $72,637.00 $1,210.00 $11,543.00 $12,196.00 $4,218.00 $20,483.00 $49,836.00 $40,341.00
Interest Expense $5,084.00 $4,869.00 $2,199.00 $3,036.00 $269,267.00 $62,928.00 $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $6,185.00 $229,378.00 $72,637.00 -$147,290.00 $179,919.00 $28,136.00 $17,550.00 -$701,104.00 $719,316.00 $192,326.00
EBITDA -$4.38 M -$3.63 M -$3.91 M $4.19 M -$2.39 M -$930,403.00 -$951,914.00 $0.00 $0.00 -$217,172.00
EBITDA Ratio -60.77 -50.29 -54.16 58.73 -58.48 -22.93 0 0 0 1.5
Operating Income Ratio -65.26 -53.47 -50.59 -38.51 -62.87 -22.93 0 -0.56 0.59 1.5
Total Other Income/Expenses Net $312,814.00 $224,509.00 -$279,732.00 $6.93 M -$464,550.00 -$82,891.00 -$375,221.00 $826,924.00 -$719,316.00 -$192,326.00
Income Before Tax -$4.39 M -$3.63 M -$3.91 M $4.18 M -$3.04 M -$1.01 M -$969,463.00 $356,536.00 -$1.11 M -$409,498.00
Income Before Tax Ratio -60.93 -50.36 -54.19 58.68 -74.23 -24.98 0 0.42 1.66 2.82
Income Tax Expense $0.00 $0.00 $1,163.00 $24,876.00 $92,348.00 $34,792.00 -$513,851.00 -$62,910.00 $696,500.00 $0.00
Net Income -$4.39 M -$3.70 M -$3.91 M $3.90 M -$3.13 M -$1.05 M -$969,463.00 $356,536.00 -$1.11 M -$409,498.00
Net Income Ratio -60.93 -51.33 -54.21 54.78 -76.48 -25.83 0 0.42 1.66 2.82
EPS -1.19 -1.2 -1.71 2.06 -2.37 -1.24 -0.99 0.5 -1.11 -0.4
EPS Diluted -1.19 -1.2 -1.71 2.03 -2.37 -1.24 -0.99 0.5 -1.11 -0.4
Weighted Average Shares Out $3.68 M $3.08 M $2.28 M $1.90 M $1.32 M $842,295.00 $982,028.00 $1.00 M $1.00 M $1.01 M
Weighted Average Shares Out Diluted $3.68 M $3.08 M $2.28 M $1.92 M $1.32 M $842,295.00 $982,028.00 $1.04 M $1.00 M $1.01 M
Link